Since an overexpression of GCS confers drug resistance and the suppression of GCS expression overcomes the resistance by enhancing drug uptake and ceramide-induced apoptosis in breast cancer cells [58,61], this suggests a mechanism that should also be considered in RCC. The gene discussed is UGCG; the disease is breast cancer.